Market Overview - Major U.S. stock index futures declined, with Dow futures down 0.89%, S&P 500 futures down 0.92%, and Nasdaq futures down 0.93% [1] Pharmaceutical Sector - Pharmaceutical giants experienced a collective drop in pre-market trading, with Novo Nordisk down over 2.5%, AstraZeneca down over 1.8%, and Pfizer and Eli Lilly down over 0.5%. This follows President Trump's demand for global pharmaceutical companies to take measures to lower drug prices in the U.S. within 60 days [1] Technology Sector - Figma saw a pre-market increase of over 12%, following a significant 250% rise in its stock price after its recent NYSE listing [1] - Apple shares rose over 2% in pre-market trading, driven by a strong earnings report for Q3 of fiscal year 2025 that exceeded Wall Street expectations. However, CEO Tim Cook noted that tariffs resulted in an $800 million loss for the quarter and could add $1.1 billion in costs for Q4 [1] - Amazon's stock fell over 7% in pre-market trading despite reporting better-than-expected revenue and profit for Q2 of 2024, as its cloud business AWS growth lagged behind competitors Microsoft and Google [1] Cryptocurrency Sector - Coinbase's stock dropped over 11% in pre-market trading due to a decline in profits for Q2 of 2024. JPMorgan lowered its target price for Coinbase from $404 to $342 [2] Technology and AI Sector - Citigroup raised Microsoft's target price to $680, citing strong performance in Q4 and accelerated growth in Azure, with a 2 percentage point increase in Azure growth forecast for the current fiscal year [2] - OpenAI announced the launch of the "Stargate" project in Norway, marking its first AI data center project in Europe, in partnership with Nscale and Aker [2] Miscellaneous - A rumor circulated about Google resuming services in mainland China on September 1, 2025, but Google denied the authenticity of the announcement [2]
网传谷歌9月1日恢复中国大陆地区服务？谷歌回应；特朗普要求降低药价，药企集体下跌；美股三大期指齐跌，亚马逊跌超7%【美股盘前】
Mei Ri Jing Ji Xin Wen·2025-08-01 11:03